The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses.
about
The Use of PET Imaging for Prognostic Integrin α2β1 Phenotyping to Detect Non-Small Cell Lung Cancer and Monitor Drug Resistance Responses.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@en
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@nl
type
label
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@en
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@nl
prefLabel
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@en
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@nl
P2093
P2860
P356
P1433
P1476
The Use of PET Imaging for Pro ...... tor Drug Resistance Responses.
@en
P2093
Chiun-Wei Huang
Chung-Pu Wu
Feng-Ting Huang
Shih-Ting Hsu
Tzu-Chen Yen
Wen-Chi Chang
Wen-Chuan Hsieh
Yi-Hsiu Chung
Yi-Wen Lin
P2860
P304
P356
10.7150/THNO.19304
P577
2017-09-20T00:00:00Z